![ALTUVIIIO® [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl] logo](/.imaging/default/dam/Marketing/AltuviiioUS/altuviiio.webp/jcr:content.webp)
Meet Daniel
“I know that I’m lucky, as a person with hemophilia, to have been born in 2003 because I was able to start on prophylaxis at 11 months old. For most of my life, all I’d known was the short infusion cycle that I was used to—I could expect protection on the first day, but I needed to be cautious on day 2.
When I started college as a freshman away from home, it was harder for me to stay on top of my treatment. Being independent meant being responsible for remembering to infuse, ordering my factor and supplies, storing it, and keeping it safe, as well as telling people around me about my diagnosis. With this new independence, classes, rowing with the team, homework, and social clubs, I struggled to keep my every-other-day infusion schedule.
When my mom found out about ALTUVIIIO and told me about it, I wanted to talk with my doctor immediately about the weekly infusion schedule and the bleed protection that ALTUVIIIO could provide. Once I got into the rhythm of my weekly routine, I felt like ALTUVIIIO just fit into my life. I love the consistency of infusing every Friday.
College is hard enough without hemophilia, but being able to infuse on a schedule that’s easy for me to remember and work into my busy week helps me focus on the things I value the most. My ALTUVIIIO treatment routine has given me (and my mom and dad) confidence that I’ll be covered with higher factor levels for longer. Not having to infuse every other day has also given me the freedom to sleep in a little bit longer before class.”
Daniel is a promotional speaker compensated by Sanofi. Peer stories based on data collected March 2026.
Get an overview of all the Peers in our network here!
Sign up for the Peer Mentor Program
Connect with a real ALTUVIIIO patient or caregiver for advice, information about their
experience, and more.
Hear from more patients
A mom and caregiver to 14-year-old Zander, who switched from an EHL to ALTUVIIIO in 2023.
An opera singer who switched from an EHL to ALTUVIIIO prophylaxis in June 2023.
Derek and Brooklynn are a father and daughter living with hemophilia and on ALTUVIIIO prophylaxis.
ALTUVIIIO® [antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl] is an injectable medicine that is used to control and reduce the number of bleeding episodes in people with hemophilia A (congenital Factor VIII deficiency).
Your healthcare provider may give you ALTUVIIIO when you have surgery.
What is the most important information I need to know about ALTUVIIIO?
Do not attempt to give yourself an injection unless you have been taught how by your healthcare provider or hemophilia center. You must carefully follow your healthcare provider’s instructions regarding the dose and schedule for injecting ALTUVIIIO so that your treatment will work best for you.
Who should not use ALTUVIIIO?
You should not use ALTUVIIIO if you have had an allergic reaction to it in the past.
What should I tell my healthcare provider before using ALTUVIIIO?
Tell your healthcare provider if you have had any medical problems, take any medications, including prescription and non-prescription medicines, supplements, or herbal medicines, are breastfeeding, or are pregnant or planning to become pregnant.
What are the possible side effects of ALTUVIIIO?
You can have an allergic reaction to ALTUVIIIO. Call your healthcare provider or emergency department right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.
Your body can also make antibodies called “inhibitors” against ALTUVIIIO. This can stop ALTUVIIIO from working properly. Your healthcare provider may give you blood tests to check for inhibitors.
The common side effects of ALTUVIIIO are headache and joint pain.
These are not the only possible side effects of ALTUVIIIO. Tell your healthcare provider about any side effect that bothers you or does not go away.
Please see full Prescribing Information.
Learn more about Sanofi’s commitment to fighting counterfeit drugs.
![ALTUVIIIO [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl] logo](/dam/jcr:0bd6aa08-1390-4c29-8440-7d6809e35b97/Altuviiio.svg)